Oxcarbazepine

Common brands: Trileptal, Oxtellar Xr, Keppra Xr, Keppra, Lamictal Xr

Top reporter: Novartis Pharmaceuticals Corporation

Anti-epileptic Agent [EPC]Benzodiazepine [EPC]Mood Stabilizer [EPC]Atypical Antipsychotic [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
31,862
Total Reports
9,742
Serious Reports
2,169
Death Reports
30
Reported Reactions
Death Report Ratio: High (6.81%)

Patient Demographics

Male
11,849
Female
16,965

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Oxcarbazepine.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 2,920
8.4%
2 SEIZURE 2,884
8.3%
3 OFF LABEL USE 1,681
4.8%
4 FATIGUE 1,633
4.7%
5 DIZZINESS 1,537
4.4%
6 CONVULSION 1,464
4.2%
7 HEADACHE 1,447
4.1%
8 SOMNOLENCE 1,434
4.1%
9 NAUSEA 1,322
3.8%
10 HYPONATRAEMIA 1,289
3.7%
11 FALL 1,205
3.5%
12 VOMITING 1,134
3.3%
13 DRUG INTERACTION 1,041
3.0%
14 RASH 996
2.9%
15 ANXIETY 982
2.8%
16 DEPRESSION 947
2.7%
17 ASTHENIA 936
2.7%
18 PAIN 925
2.7%
19 EPILEPSY 897
2.6%
20 CONDITION AGGRAVATED 847
2.4%
21 DIARRHOEA 800
2.3%
22 WEIGHT INCREASED 769
2.2%
23 PYREXIA 768
2.2%
24 INSOMNIA 766
2.2%
25 DYSPNOEA 748
2.1%
26 TREMOR 733
2.1%
27 BALANCE DISORDER 724
2.1%
28 MALAISE 706
2.0%
29 MEMORY IMPAIRMENT 706
2.0%
30 FEELING ABNORMAL 630
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.